PH12015502280A1 - Transdermal delivery system comprising donepezil or its salt - Google Patents

Transdermal delivery system comprising donepezil or its salt

Info

Publication number
PH12015502280A1
PH12015502280A1 PH12015502280A PH12015502280A PH12015502280A1 PH 12015502280 A1 PH12015502280 A1 PH 12015502280A1 PH 12015502280 A PH12015502280 A PH 12015502280A PH 12015502280 A PH12015502280 A PH 12015502280A PH 12015502280 A1 PH12015502280 A1 PH 12015502280A1
Authority
PH
Philippines
Prior art keywords
molecular weight
donepezil
weight
drug
delivery system
Prior art date
Application number
PH12015502280A
Other languages
English (en)
Other versions
PH12015502280B1 (en
Inventor
Choi Yo-Han
Chang Hee-Chul
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of PH12015502280A1 publication Critical patent/PH12015502280A1/en
Publication of PH12015502280B1 publication Critical patent/PH12015502280B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH12015502280A 2014-01-22 2015-09-30 Transdermal delivery system comprising donepezil or its salt PH12015502280B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20140007556A KR101485822B1 (ko) 2014-01-22 2014-01-22 도네페질 또는 그의 염을 함유하는 경피흡수제제
PCT/KR2015/000277 WO2015111862A1 (fr) 2014-01-22 2015-01-12 Système d'administration transdermique comprenant du donépézil ou un sel de ce dernier

Publications (2)

Publication Number Publication Date
PH12015502280A1 true PH12015502280A1 (en) 2016-02-01
PH12015502280B1 PH12015502280B1 (en) 2016-02-01

Family

ID=52592456

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015502280A PH12015502280B1 (en) 2014-01-22 2015-09-30 Transdermal delivery system comprising donepezil or its salt

Country Status (11)

Country Link
US (1) US9931307B2 (fr)
EP (1) EP3096745B1 (fr)
JP (1) JP6405391B2 (fr)
KR (1) KR101485822B1 (fr)
CN (1) CN105025890B (fr)
AU (1) AU2015209915B2 (fr)
BR (1) BR112015024271B1 (fr)
CA (1) CA2908340C (fr)
ES (1) ES2874508T3 (fr)
PH (1) PH12015502280B1 (fr)
WO (1) WO2015111862A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108778272A (zh) * 2015-12-10 2018-11-09 Km特兰斯达股份有限公司 经皮吸收制剂
IL303255A (en) 2015-12-30 2023-07-01 Corium Inc Systems and methods for long-term percutaneous administration
EP3474831A1 (fr) 2016-06-23 2019-05-01 Corium International, Inc. Matrice adhésive à un domaine hydrophile, un domaine hydrophobes et un agent thérapeutique
CN109789106B (zh) 2016-07-27 2023-06-27 考里安有限责任公司 碳酸氢钠原位转化驱动胺药物的透皮递送
KR102424270B1 (ko) 2016-07-27 2022-07-25 코리움, 인크. 경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템
SG11201900712SA (en) 2016-07-27 2019-02-27 Corium Int Inc Memantine transdermal delivery systems
WO2019126531A1 (fr) 2017-12-20 2019-06-27 Corium, Inc. Composition adhésive transdermique comprenant un agent thérapeutique liquide volatil à bas point de fusion
KR102024996B1 (ko) 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
KR102372630B1 (ko) 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제
KR102218593B1 (ko) * 2020-05-13 2021-02-22 동아에스티 주식회사 안정성이 향상된 도네페질 함유 경피 흡수제제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
KR100342388B1 (ko) * 1999-11-03 2002-07-04 김충섭 경피 투과용 약물 전달 시스템
JP4394443B2 (ja) 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
KR100623077B1 (ko) * 2002-08-26 2006-09-18 지상철 에스(+)-이부프로펜을 함유하는 경피투여용 조성물 및이를 함유하는 경피투여용 패취제
KR100682729B1 (ko) * 2004-06-15 2007-02-15 (주)아모레퍼시픽 신규 경피흡수제제 및 그 제조방법
EP2316437B1 (fr) * 2005-05-13 2014-07-30 Alza Corporation Système d'administration de médicaments multicouche avec protection contre le flux de matériaux du réservoir
JP5097359B2 (ja) * 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
KR101454362B1 (ko) 2008-03-24 2014-10-23 아이큐어 주식회사 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
EP2328582A4 (fr) 2008-09-30 2012-02-22 Teikoku Pharma Usa Inc Compositions de donépézil à administration transdermique étendue et leurs procédés d'utilisation
EP2399607B1 (fr) 2009-02-18 2017-11-29 Hisamitsu Pharmaceutical Co., Inc. Préparation transdermique
KR101325104B1 (ko) 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
BR112012011334A2 (pt) * 2009-10-21 2020-08-25 Teikoku Seiyaku Co., Ltd. formulação transdermicamente absorvível contendo donepezil
JP5766475B2 (ja) 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
KR101292768B1 (ko) * 2010-04-23 2013-08-05 아이큐어 주식회사 경피 흡수 제제
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
CN102895217A (zh) * 2012-11-13 2013-01-30 沈阳药科大学 长效多奈哌齐经皮吸收贴剂

Also Published As

Publication number Publication date
AU2015209915A1 (en) 2015-08-27
KR101485822B1 (ko) 2015-01-23
EP3096745A4 (fr) 2017-08-02
WO2015111862A1 (fr) 2015-07-30
ES2874508T3 (es) 2021-11-05
CA2908340A1 (fr) 2015-07-30
BR112015024271B1 (pt) 2023-10-31
BR112015024271A2 (pt) 2017-07-18
JP6405391B2 (ja) 2018-10-17
CA2908340C (fr) 2021-11-30
US20160051486A1 (en) 2016-02-25
EP3096745B1 (fr) 2021-05-12
PH12015502280B1 (en) 2016-02-01
CN105025890A (zh) 2015-11-04
AU2015209915B2 (en) 2019-09-12
CN105025890B (zh) 2020-03-10
JP2017503865A (ja) 2017-02-02
EP3096745A1 (fr) 2016-11-30
US9931307B2 (en) 2018-04-03

Similar Documents

Publication Publication Date Title
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
MX2017003623A (es) Parche de opipramol.
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
MY163809A (en) Transdermal drug delivery system containing donepezil
MX362838B (es) Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
PH12017502376B1 (en) Oral solid formulation containing irinotecan and method of preparing the same
CA3010568A1 (fr) Supports nanofibreux oromumuqueux pour traitement therapeutique
WO2015023649A3 (fr) Peptides destinés à améliorer l'administration transdermique
WO2018213815A3 (fr) Lyse synthétique régulée par quorum
WO2018085495A3 (fr) Films dissolubles et leurs procédés d'utilisation
EP3539978A4 (fr) Fragment de nkx3.2 et composition pharmaceutique le comprenant en tant que principe actif
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
PH12016501500A1 (en) Topical formulations of heparin
IN2013MU03370A (fr)
WO2019098691A3 (fr) Composition et procédé de lyophilisation d'une composition pharmaceutique contenant un médicament anionique
MY162768A (en) Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
PH12016502527B1 (en) Stabilized desmopressin
TH170461A (th) "ระบบส่งผ่านหนังซึ่งประกอบรวมด้วยโดนีพีซิล หรือเกลือของมัน"
WO2021108151A3 (fr) Système d'administration transdermique
WO2016108507A3 (fr) Comprimé composite destiné à une administration orale comprenant de la mélatonine et de la sertraline
MX2018001320A (es) Sistema de administracion transdermica.